Cargando…

Infantile hemangiomas: a 7-year experience of a single-center

OBJECTIVES: The aim of the study was to describe the historical and clinical characteristics of hemangiomas in a series of cases of our clinic. METHODS: This is a retrospective study of 36 patients with infantile hemangiomas consulted in our clinic. RESULTS: We had 14 multiple hemangiomas, and 1 kap...

Descripción completa

Detalles Bibliográficos
Autores principales: BOTA, MĂDĂLINA, POPA, GHEORGHE, BLAG, CRISTINA LUCIA, LEUCUTA, DANIEL-CORNELIU, TĂTARU, ALEXANDRU
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683828/
https://www.ncbi.nlm.nih.gov/pubmed/29151787
http://dx.doi.org/10.15386/cjmed-781
_version_ 1783278367829655552
author BOTA, MĂDĂLINA
POPA, GHEORGHE
BLAG, CRISTINA LUCIA
LEUCUTA, DANIEL-CORNELIU
TĂTARU, ALEXANDRU
author_facet BOTA, MĂDĂLINA
POPA, GHEORGHE
BLAG, CRISTINA LUCIA
LEUCUTA, DANIEL-CORNELIU
TĂTARU, ALEXANDRU
author_sort BOTA, MĂDĂLINA
collection PubMed
description OBJECTIVES: The aim of the study was to describe the historical and clinical characteristics of hemangiomas in a series of cases of our clinic. METHODS: This is a retrospective study of 36 patients with infantile hemangiomas consulted in our clinic. RESULTS: We had 14 multiple hemangiomas, and 1 kaposiform hemangioendothelioma. Almost two-thirds involved the cephalic extremity, and 76% of the cases were treated. Pregnancy risk factors included prematurity, low-birth weight and respiratory distress syndrome. Propranolol was used in 22 cases, followed by prednisone in 3 cases. Vincristine and interferon were used as associated therapies or as second line therapies. Two hemangiomas had complications, one ulceration and a Kasabach-Merritt syndrome. All the patients had a good evolution. CONCLUSIONS: Our study results regarding the involvement of pregnancy and birth risk factors in developing infantile hemangiomas is similar to literature data. The majority of patients had at least one risk factor suggesting that at least one trigger to develop an infantile hemangioma is necessary. Our study shows that the cephalic extremity is mostly involved, and because of its potential complications they are most likely to be treated. The study shows that propranolol is the leading treatment option with few and mild side effects.
format Online
Article
Text
id pubmed-5683828
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Iuliu Hatieganu University of Medicine and Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-56838282017-11-17 Infantile hemangiomas: a 7-year experience of a single-center BOTA, MĂDĂLINA POPA, GHEORGHE BLAG, CRISTINA LUCIA LEUCUTA, DANIEL-CORNELIU TĂTARU, ALEXANDRU Clujul Med Original Research OBJECTIVES: The aim of the study was to describe the historical and clinical characteristics of hemangiomas in a series of cases of our clinic. METHODS: This is a retrospective study of 36 patients with infantile hemangiomas consulted in our clinic. RESULTS: We had 14 multiple hemangiomas, and 1 kaposiform hemangioendothelioma. Almost two-thirds involved the cephalic extremity, and 76% of the cases were treated. Pregnancy risk factors included prematurity, low-birth weight and respiratory distress syndrome. Propranolol was used in 22 cases, followed by prednisone in 3 cases. Vincristine and interferon were used as associated therapies or as second line therapies. Two hemangiomas had complications, one ulceration and a Kasabach-Merritt syndrome. All the patients had a good evolution. CONCLUSIONS: Our study results regarding the involvement of pregnancy and birth risk factors in developing infantile hemangiomas is similar to literature data. The majority of patients had at least one risk factor suggesting that at least one trigger to develop an infantile hemangioma is necessary. Our study shows that the cephalic extremity is mostly involved, and because of its potential complications they are most likely to be treated. The study shows that propranolol is the leading treatment option with few and mild side effects. Iuliu Hatieganu University of Medicine and Pharmacy 2017 2017-10-20 /pmc/articles/PMC5683828/ /pubmed/29151787 http://dx.doi.org/10.15386/cjmed-781 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
spellingShingle Original Research
BOTA, MĂDĂLINA
POPA, GHEORGHE
BLAG, CRISTINA LUCIA
LEUCUTA, DANIEL-CORNELIU
TĂTARU, ALEXANDRU
Infantile hemangiomas: a 7-year experience of a single-center
title Infantile hemangiomas: a 7-year experience of a single-center
title_full Infantile hemangiomas: a 7-year experience of a single-center
title_fullStr Infantile hemangiomas: a 7-year experience of a single-center
title_full_unstemmed Infantile hemangiomas: a 7-year experience of a single-center
title_short Infantile hemangiomas: a 7-year experience of a single-center
title_sort infantile hemangiomas: a 7-year experience of a single-center
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683828/
https://www.ncbi.nlm.nih.gov/pubmed/29151787
http://dx.doi.org/10.15386/cjmed-781
work_keys_str_mv AT botamadalina infantilehemangiomasa7yearexperienceofasinglecenter
AT popagheorghe infantilehemangiomasa7yearexperienceofasinglecenter
AT blagcristinalucia infantilehemangiomasa7yearexperienceofasinglecenter
AT leucutadanielcorneliu infantilehemangiomasa7yearexperienceofasinglecenter
AT tatarualexandru infantilehemangiomasa7yearexperienceofasinglecenter